Bruker reported $184.9M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
ABB USD 3.81B 57M Sep/2026
Agilent USD 1.76B 49M Jun/2026
Ametek USD 666.15M 170.71M Sep/2026
Bio Techne USD 350.04M 85.32M Sep/2026
Bio-Rad Laboratories USD 465.3M 51.7M Sep/2026
Bruker USD 184.9M 51.5M Jun/2026
Charles River Laboratories USD 200.38M 8.36M Sep/2026
Danaher USD 5.68B 1.33B Sep/2026
Fujikura JPY 181.22B 27.23B Mar/2026
Furukawa JPY 21.05B 5.58B Mar/2026
General Electric Aerospace USD 8.76B 581M Sep/2026
Hitachi JPY 1.5T 181.02B Jun/2026
Illumina USD 1.29B 249M Sep/2026
IQVIA Holdings USD 2.25B 340M Sep/2026
Mettler Toledo International USD 52.24M 854K Sep/2026
Mitsubishi Electric JPY 731.61B 131.23B Mar/2026
Mitsubishi Heavy Industries JPY 1.68T 349.21B Jun/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
Nikon Corporation JPY 158.04B 6.7B Mar/2026
Olympus JPY 157.74B 10.5B Sep/2026
Repligen USD 726.96M 120.18M Sep/2026
Revvity USD 592.8M 430.14M Sep/2026
Smiths GBP 2.96B 2.61B Dec/2026
Thermo Fisher Scientific USD 5.46B 1.4B Sep/2026
Waters USD 593M 54M Sep/2026